Workflow
制氧仪
icon
Search documents
健康器械迎来品牌化突围期,天猫正在成为新锐品牌的加速器
36氪未来消费· 2025-06-17 13:16
品牌红利从未消失,只是换了路径。 一个有趣的现象正在发生 。 健康管理的重心,正在从 "治病"逐步转向"保健 "。 新锐品牌接棒:健康器械三大变革趋势浮现 过去 , 健康器械主要活跃在 "院线"和医疗机构的专业场景里,如今,它正加速走向更广泛的大众市场。 "这些变化并不是偶然的,而是消费需求和产品供给同时迁移的结果。"天猫健康器械行业负责人奥钉表示。站在平台视角,行业正呈现出三 大趋势: 其一,院线器械家用化。如制氧仪、血糖仪、脱毛仪等院线设备开始被普通消费者在家使用,甚至扩展至高原旅行、健身等全新的使用场 景。 其二,消费品医疗化。具备医疗注册证的冲牙器、护理垫等产品,因其更高的标准获得消费者青睐, 315后妇科护理垫类目的爆发便是例 证。 过去主要服务于病患的专业设备,如今已快速嵌入人们的日常生活。我们可以看到, CGM(动态血糖仪)被健身人群用于体能管理,制氧机 进入户外场景,洗鼻器成为鼻炎患者的日常选项。 与之对应的是整个类目的快速成长。公开数据显示, 健康器械已成为淘天健康赛道中增速最快的细分类之一 。天猫健康行业营销负责人姜夏 对 36氪透露 : "器械品类正在从专业用途向大众适配迁移,我们观察到 ...
探访欧姆龙大连工厂 “智律波”让测量血压的同时提示房颤风险
Sou Hu Cai Jing· 2025-04-29 02:00
Core Viewpoint - Omron has established itself as a leader in health care devices, particularly in blood pressure monitors, and is expanding its innovative technologies to address cardiovascular risks, particularly atrial fibrillation [1][6][8]. Group 1: Company Overview - Omron established its first factory in China in 1993, making the Dalian facility the largest global production base for Omron's health care division [1]. - The company operates in four major business areas: health care, industrial automation, electronic components, and social solutions [2]. Group 2: Innovative Technology - The "Intellisense Afib" technology allows blood pressure monitors to simultaneously detect the risk of atrial fibrillation during blood pressure measurement [8]. - This technology is based on 50 years of pulse wave data and integrates AI to enhance the accuracy of atrial fibrillation detection [8]. Group 3: Market Position and Strategy - China accounts for 33% of Omron's global health care sales, highlighting its significance as a key market [6]. - The aging population and the rise of health-conscious younger generations present substantial growth opportunities for Omron's products [6]. Group 4: Product Development - The new generation blood pressure monitor, HCG-7800T, improves accuracy and ease of use, allowing for simultaneous blood pressure and atrial fibrillation detection [9]. - Omron has sold over 350 million home blood pressure monitors globally as of April 2023, indicating strong market penetration [11]. Group 5: Future Vision - Omron aims to achieve three zeros in its health care business: zero occurrences of cardiovascular events, zero deterioration of respiratory diseases, and zero limitations in daily life due to chronic pain [14].